Immediate Effects of Kinesio Taping in Primary Dysmenorrhea
The Immediate Effect of Kinesio Taping on Pain, Menstrual Symptoms, Fear of Movement, and Sleep Quality in Primary Dysmenorrhea: A Randomized Sham-Controlled Trial
1 other identifier
interventional
24
1 country
1
Brief Summary
Primary dysmenorrhea is characterized by recurrent, cramping lower abdominal pain during menstruation and affects approximately 50% to 90% of women. The etiology of primary dysmenorrhea involves the increased release of prostaglandins and other inflammatory mediators, which cause uterine contractions and reduced blood flow. In addition to pharmacological approaches, non-pharmacological methods also play an important role in the treatment of dysmenorrhea. Kinesio taping helps relieve pain by reducing pressure on the muscle and supports treatment through various application techniques. It improves local circulation, reduces muscle tension, and alleviates symptoms of primary dysmenorrhea. The aim of this study is to investigate the effects of kinesio taping on pain, menstrual symptoms, fear of movement, and sleep quality in women with primary dysmenorrhea, and to compare the outcomes with those of a sham taping group. The hypothesis is that kinesio taping will be more effective than sham taping in improving these parameters in women with primary dysmenorrhea.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Aug 2023
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 19, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 15, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 23, 2023
CompletedFirst Submitted
Initial submission to the registry
May 17, 2025
CompletedFirst Posted
Study publicly available on registry
May 25, 2025
CompletedApril 17, 2026
April 1, 2026
4 months
May 17, 2025
April 14, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
Visual Analog Scale
Pain will be assessed using the Visual Analog Scale. On the Visual Analog Scale, a score of '0' indicates no pain, while '10' represents the most unbearable pain on a 10 cm horizontal line. It is a simple, practical, valid, reliable, and reproducible measurement tool.
2 weeks
Menstrual Symptom Questionnaire
The Menstrual Symptom Questionnaire (MSQ) was originally developed by Chesney and Tasto in 1975 to evaluate menstrual pain and related symptoms. Participants rate the severity of symptoms they experience during menstruation on a scale from 1 (never) to 5 (always). In this scale: Items 1-13 assess negative effects, Items 14-19 assess menstrual pain symptoms, and Items 20-22 assess coping methods. As the average score of each subscale increases, it indicates a higher severity of menstrual symptoms related to that subscale.
2 weeks
Menstrual Attitude and Behavior Scale
The Menstrual Attitude and Behavior Scale will be used to assess individuals' attitudes and behaviors during the menstrual period. This scale, also known as the Menstrual Attitude Questionnaire, consists of 33 items divided into five subscales: Menstruation as a debilitating event - 12 items Menstruation as a bothersome event - 6 items Menstruation as a natural event - 5 items Anticipation of the onset of menstruation - 5 items Denial of menstrual effects - 7 items Each subscale provides insight into specific attitudes and perceptions related to menstruation.
2 weeks
Tampa Scale of Kinesiophobia
Fear of movement will be assessed using the Tampa Scale of Kinesiophobia. The scale uses a 4-point Likert-type scoring system, and the total score ranges from 17 to 68. Higher scores indicate a greater fear of movement.
2 weeks
Richard Campbell Sleep Questionnaire
The Richard Campbell Sleep Questionnaire was developed by Richards in 1987 to assess sleep depth, time taken to fall asleep, number of awakenings, duration of wakefulness after sleep onset, sleep quality, and environmental noise level. It consists of 6 items, each evaluated using a visual analog scale ranging from 0 to 100. A score between 0-25 indicates very poor sleep, while a score between 76-100 reflects very good sleep. The total score is calculated based on 5 items; the 6th item, which evaluates environmental noise level, is excluded from the total score. Higher total scores indicate better sleep quality.
2 weeks
Study Arms (2)
Kinesio Taping Group
EXPERIMENTALSham Control Group
SHAM COMPARATORInterventions
In the application over the sacrum, one I-strip of kinesio tape will be applied with 25% tension using the fascia correction technique, which requires oscillatory movements between the tape and the skin. In the application over the suprapubic region, two I-strips will be applied with 25% tension, also using the fascia correction technique, involving oscillations between the tape and the skin.
In the application over the sacrum, one I-strip will be applied without tension. In the application over the suprapubic region, two I-strips will be placed without tension.
Eligibility Criteria
You may qualify if:
- Being a nulliparous woman aged between 18 and 24 years
- Having a diagnosis of primary dysmenorrhea confirmed by a physician,
- Being literate
- Cooperating in completing the assessment scales
- Scoring one or above on the Weissman Scale
- Agreeing to participate in the study
- Having regular menstruation in the last 6 months
- Being willing and voluntary to participate in the research.
You may not qualify if:
- Having a diagnosis of secondary dysmenorrhea
- Using contraceptive pills
- Having a history of childbirth or pregnancy
- Having irregular menstrual cycles (menstrual cycle length less than 21 days or longer than 35 days)
- Having any pelvic pathology or history of pelvic surgery
- Having gastrointestinal, urogynecological, autoimmune, psychiatric, neurological diseases, or other chronic pain syndromes.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Okan Universitylead
Study Sites (1)
Istanbul Okan University
Istanbul, 34010, Turkey (Türkiye)
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assos. Prof
Study Record Dates
First Submitted
May 17, 2025
First Posted
May 25, 2025
Study Start
August 19, 2023
Primary Completion
December 15, 2023
Study Completion
December 23, 2023
Last Updated
April 17, 2026
Record last verified: 2026-04